Welcome
Support Centre
23 May 2012 
ISRCTN Register - International Standard Randomized Controlled Trial Number
Trial registration
Unique identification scheme
International databases
home  |   my details  |   ISRCTN Register  |   mRCT  |   links  |   information  |   press
Find trials
ISRCTN Register
tips on searching

Registration
New application
Updating record

Information
introduction
governing board
ISRCTN FAQs
data set
letter of agreement
request information
guidance notes

[ Print-friendly version ]
Aspirin in in vitro fertilisation (IVF)
ISRCTN ISRCTN97507474
ClinicalTrials.gov identifier
Public title Aspirin in in vitro fertilisation (IVF)
Scientific title Added 26/08/09: Low dose aspirin in IVF. A prospective, randomised, double blind placebo controlled trial.
Acronym N/A
Serial number at source NTR610
Study hypothesis By its pharmacological action it is likely that aspirin improves ovarian perfusion, uterine perfusion and reduces endometrial restraint on the implanting embryo. Therefore the hypothesis of this study is that the use of low dose aspirin in IVF improves pregnancy rates.
Lay summary
Ethics approval Received from local medical ethics committee
Study design Prospective randomised double blind placebo controlled parallel group trial
Countries of recruitment Netherlands
Disease/condition/study domain Subfertility
Participants - inclusion criteria 1. Patients undergoing IVF or intracytoplasmic sperm injection (ICSI) treatment
2. Age <39 years
3. Cycle day 3 follicle stimulating hormone (FSH) <10 IU/l
4. No contra-indications against the use of low-dose aspirin
Participants - exclusion criteria 1. Systemic diseases
2. Hypertension
3. Previous allergic reaction to study medication
4. Previous ovarian hyperstimulation syndrome (OHSS)
5. Untreated endocrinopathies
6. Smoking >5 cigarettes/day
7. Body mass index (BMI) >28
Anticipated start date 01/06/2002
Anticipated end date 01/08/2007
Status of trial Completed
Patient information material
Target number of participants 150
Interventions Patients undergo regular IVF/ICSI treatment combined with low dose aspirin or placebo.
Primary outcome measure(s) Ongoing pregnancy rate
Secondary outcome measure(s) 1. Number of follicles
2. Number of oocytes retrieved
Sources of funding VU University Medical Centre (VUMC) (Netherlands) - Department of Obstetrics and Gynaecology, Division of Reproductive Medicine
Trial website
Publications 2008 results in http://www.ncbi.nlm.nih.gov/pubmed/18973893
Contact name Dr  P.G.A.  Hompes
  Address VU University Medical Center
Department of Obstetrics and Gynaecology
P.O. Box 7057
  City/town Amsterdam
  Zip/Postcode 1007 MB
  Country Netherlands
  Tel +31 (0)20 4444444
  Email p.hompes@vumc.nl
Sponsor VU University Medical Centre (VUMC) (Netherlands)
  Address Department of Obstetrics and Gynaecology,
Division of Reproductive Medicine
P.O. Box 7057
  City/town Amsterdam
  Zip/Postcode 1007 MB
  Country Netherlands
Date applied 04/04/2006
Last edited 26/08/2009
Date ISRCTN assigned 04/04/2006
Submit your trial protocol
Submit to Trials journal
Follow us on Twitter
© 2012 ISRCTN unless otherwise stated.


BioMed Central